查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1509631

2024 年內分泌檢測全球市場報告

Endocrine Testing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

內分泌檢測市場規模預計在未來幾年將強勁成長。 2028年，這一數字將以9.6%的複合年成長率成長至36.7億美元。預測期內的預期成長是由多種因素推動的，包括內分泌疾病患病率的增加、國防開支的增加、人口老齡化、意識和早期診斷工作的提高以及對內分泌健康的整體認知的提高。認為是由多種因素造成的。預測期內預期的主要趨勢包括生物標記檢測技術的進步、體學技術的整合、利用人工智慧和機器學習進行診斷、強調品質保證和標準化措施、合作研究工作和翻譯這包括強調民族醫學接近。

糖尿病盛行率的上升趨勢預計將在短期內推動內分泌檢測市場的成長。糖尿病的特徵是血糖值升高，由於多種因素，包括不健康的飲食模式、久坐的生活方式、遺傳傾向和衰老，其發病率正在上升。內分泌檢測在糖尿病管理中發揮重要作用，包括血紅蛋白 A1c、空腹血糖和 C胜肽檢測等檢測，以診斷病情、監測血糖濃度並評估胰島素的產生和敏感性。例如，國際糖尿病聯盟2021年發布的資料顯示，全球約有5.37億成年人（20歲至79歲）患有糖尿病。據預測，2030年這數字將進一步增加至6.43億人，2045年將達到7.83億人。因此，糖尿病盛行率的快速上升刺激了內分泌檢測市場的需求。

內分泌檢測市場的主要參與企業正在專注於開發就地檢驗解決方案，以提高診斷內分泌疾病的可及性和效率。就地檢驗可以快速獲得結果，並有助於快速診斷和管理出現呼吸急促和疲勞等症狀的患者的心臟衰竭等疾病。例如，2024 年 4 月，瑞士製藥公司羅氏控股公司在印度推出了照護現場NT-proBNP 檢測。該測試專門用於篩檢心臟衰竭（HF）等心血管疾病風險的糖尿病患者，促進早期發現和早期療育。該測試使臨床醫生能夠快速識別高風險 T2D 患者並及時啟動治療，最終改善結果和患者福祉。

目錄

第1章執行概述

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球內分泌檢測市場：促進因素與抑制因素
    • 市場促進因素
    • 市場限制因素
  • 全球內分泌檢測市場表現：規模與成長，2018-2023
  • 全球內分泌檢測市場預測：規模與成長，2023-2028、2033

第6章 市場細分

  • 全球內分泌檢測市場：依檢測類型分類的表現與預測，2018-2023年、2023-2028年、2033年
  • 雌二醇（E2）測試
  • 濾泡刺激素(FSH) 測試
  • 人類絨毛膜促性腺激素分泌(hCG) 荷爾蒙測試
  • 黃體激素（LH）測試
  • 硫酸去氫表雄酮（DHEAS）測試
  • 黃體酮測試
  • 睪酮測試
  • 甲狀腺刺激素（TSH）測試
  • 催乳素測試
  • 其他
  • 全球內分泌檢測市場：依技術、效能和預測分類，2018-2023年、2023-2028年、2033年
  • 串聯式質譜質譜法
  • 免疫檢測
  • 單株和多株抗體技術
  • 感測器技術
  • 臨床化學
  • 其他
  • 全球內分泌檢測市場：按最終用戶、效能和預測，2018-2023、2023-2028、2033
  • 醫院
  • 臨床實驗室
  • 診斷中心
  • 其他

第 7 章 區域/國家分析

  • 全球內分泌檢測市場：按地區、績效及預測，2018-2023年、2023-2028年、2033年
  • 全球內分泌檢測市場：依國家、績效及預測，2018-2023年、2023-2028年、2033年

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 內分泌檢測市場：競爭格局
  • 內分泌檢測市場：公司簡介
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Roche Holding
    • Siemens Healthineers
    • Quest Diagnostics

第31章 其他大型創新企業

  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • BioMerieux SA
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • SD Biosensor Inc.
  • Qiagen NV
  • Ortho Clinical Diagnostics
  • Kronus Inc.
  • Randox Laboratories Ltd.
  • Fujirebio Diagnostics Inc.
  • Inova Diagnostics Inc.
  • Sekisui Diagnostics LLC
  • Mercodia AB
  • ZEUS Scientific Inc.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來展望與潛力分析

第36章附錄

簡介目錄
Product Code: r18128

Endocrine testing involves the diagnostic assessment of hormone levels within the body, typically conducted through blood, urine, or saliva analyses, to evaluate the function of the endocrine system. These tests play a vital role in diagnosing a range of endocrine disorders, such as diabetes, thyroid disorders, adrenal insufficiency, and pituitary gland disorders, enabling healthcare providers to formulate appropriate treatment and management plans for affected patients.

The primary types of endocrine testing encompass various assessments including the estradiol (E2) test, follicle-stimulating hormone (FSH) test, human chorionic gonadotropin (HCG) hormone test, luteinizing hormone (LH) test, dehydroepiandrosterone sulfate (DHEAS) test, progesterone test, testosterone test, thyroid-stimulating hormone (TSH) test, prolactin test, among others. For instance, the Estradiol (E2) Test involves a blood test to measure estradiol levels in the body. These tests utilize diverse technologies such as tandem mass spectrometry, immunoassays, monoclonal and polyclonal antibody technologies, sensor technology, clinical chemistry, among others, and are commonly conducted in hospitals, clinical laboratories, diagnostic centers, and similar healthcare facilities.

The endocrine testing market research report is one of a series of new reports from The Business Research Company that provides endocrine testing market statistics, including endocrine testing industry global market size, regional shares, competitors with a endocrine testing market share, detailed endocrine testing market segments, market trends and opportunities, and any further data you may need to thrive in the endocrine testing industry. This endocrine testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endocrine testing market size has grown strongly in recent years. It will grow from $2.33 billion in 2023 to $2.55 billion in 2024 at a compound annual growth rate (CAGR) of 9.4%. The growth observed in the historical period can be attributed to several key factors, including the discovery of hormones and endocrine pathways, the standardization of diagnostic tests, the implementation of public health initiatives, and the increased advocacy and empowerment of patients.

The endocrine testing market size is expected to see strong growth in the next few years. It will grow to $3.67 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The anticipated growth in the forecast period can be attributed to various factors, including the growing prevalence of endocrine disorders, heightened defense spending, an aging population, increased awareness and early diagnosis initiatives, and heightened overall awareness regarding endocrine health. Key trends expected in the forecast period encompass advancements in biomarker detection techniques, the integration of omics technologies, the utilization of artificial intelligence and machine learning for diagnostic purposes, a focus on quality assurance and standardization measures, and an emphasis on collaborative research efforts and translational medicine approaches.

The upward trend in diabetes prevalence is anticipated to drive the growth of the endocrine testing market in the foreseeable future. Diabetes, a condition characterized by elevated blood sugar levels, is on the rise due to various factors such as unhealthy dietary patterns, sedentary lifestyles, genetic predisposition, and an aging population. Endocrine testing plays a crucial role in diabetes management, encompassing tests such as hemoglobin A1c, fasting plasma glucose, and C-peptide tests to diagnose the condition, monitor glucose levels, and evaluate insulin production and sensitivity. For instance, data from the International Diabetes Federation in 2021 revealed that approximately 537 million adults (aged 20-79 years) globally were living with diabetes. Projections indicate a further increase to 643 million by 2030 and 783 million by 2045. Consequently, the surge in diabetes prevalence is stimulating demand within the endocrine testing market.

Key players in the endocrine testing market are focusing on developing point-of-care testing solutions to enhance accessibility and efficiency in diagnosing endocrine disorders. Point-of-care testing enables rapid results, aiding in prompt diagnosis and management of conditions such as heart failure in patients displaying symptoms such as shortness of breath and fatigue. For example, in April 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, introduced a point-of-care NT-proBNP test in India. This test is specifically tailored for screening diabetes patients at risk of cardiovascular diseases such as heart failure (HF), facilitating early detection and intervention. It empowers clinicians to identify high-risk T2D patients promptly and initiate timely treatment discussions, ultimately leading to improved outcomes and patient well-being.

In October 2022, Tolmar, a US-based pharmaceutical company, acquired Jatenzo from Clarus Therapeutics, although the financial details remain undisclosed. This acquisition aligns with Tolmar's focus on pediatric endocrinology and men's health, augmenting their portfolio of specialty pharmaceutical products. Clarus Therapeutics, a US-based pharmaceutical company, specializes in developing and commercializing therapies for individuals with endocrine disorders.

Major companies operating in the endocrine testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Holding, Siemens Healthineers, Quest Diagnostics, Agilent Technologies Inc., PerkinElmer Inc., BioMerieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., Qiagen N.V., Ortho Clinical Diagnostics, Kronus Inc., Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Inova Diagnostics Inc., Sekisui Diagnostics LLC, Mercodia AB, ZEUS Scientific Inc., IBL International, Monobind Inc., Agilus Diagnostics, Tosoh Bioscience Inc., DiaSorin S.p.A.

North America was the largest region in the endocrine testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the endocrine testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endocrine testing market consists of revenues earned by entities by providing services such as hormone level testing, thyroid function testing, diabetes testing, adrenal function testing, reproductive hormone testing, pituitary function testing, and bone metabolism testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The endocrine testing market also includes sales of assay kits, analyzers, point-of-care testing devices, reagents, software solutions, quality control materials, and calibrators and controls. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endocrine Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endocrine testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endocrine testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The endocrine testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Estradiol (E2) Test; Follicle Stimulating Hormone (FSH) Test; Human Chorionic Gonadotropin (hCG) Hormone Test; Luteinizing Hormone (LH) Test; Dehydroepiandrosterone Sulfate (DHEAS) Test; Progesterone Test; Testosterone Test; Thyroid Stimulating Hormone (TSH) Test; Prolactin Test; Other Types
  • 2) By Technology: Tandem Mass Spectrometry; Immunoassay; Monoclonal & Polyclonal Antibody Technologies; Sensor Technology; Clinical Chemistry; Other Technologies
  • 3) By End-User: Hospitals; Clinical Laboratories; Diagnostic Centers; Other End-Users
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Roche Holding; Siemens Healthineers; Quest Diagnostics
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Endocrine Testing Market Characteristics

3. Endocrine Testing Market Trends And Strategies

4. Endocrine Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Endocrine Testing Market Size and Growth

  • 5.1. Global Endocrine Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Endocrine Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Endocrine Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Endocrine Testing Market Segmentation

  • 6.1. Global Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Estradiol (E2) Test
  • Follicle Stimulating Hormone (FSH) Test
  • Human Chorionic Gonadotropin (hCG) Hormone Test
  • Luteinizing Hormone (LH) Test
  • Dehydroepiandrosterone Sulfate (DHEAS) Test
  • Progesterone Test
  • Testosterone Test
  • Thyroid Stimulating Hormone (TSH) Test
  • Prolactin Test
  • Other Types
  • 6.2. Global Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Tandem Mass Spectrometry
  • Immunoassay
  • Monoclonal And Polyclonal Antibody Technologies
  • Sensor Technology
  • Clinical Chemistry
  • Other Technologies
  • 6.3. Global Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinical Laboratories
  • Diagnostic Centers
  • Other End-Users

7. Endocrine Testing Market Regional And Country Analysis

  • 7.1. Global Endocrine Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Endocrine Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Endocrine Testing Market

  • 8.1. Asia-Pacific Endocrine Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Endocrine Testing Market

  • 9.1. China Endocrine Testing Market Overview
  • 9.2. China Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Endocrine Testing Market

  • 10.1. India Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Endocrine Testing Market

  • 11.1. Japan Endocrine Testing Market Overview
  • 11.2. Japan Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Endocrine Testing Market

  • 12.1. Australia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Endocrine Testing Market

  • 13.1. Indonesia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Endocrine Testing Market

  • 14.1. South Korea Endocrine Testing Market Overview
  • 14.2. South Korea Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Endocrine Testing Market

  • 15.1. Western Europe Endocrine Testing Market Overview
  • 15.2. Western Europe Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Endocrine Testing Market

  • 16.1. UK Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Endocrine Testing Market

  • 17.1. Germany Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Endocrine Testing Market

  • 18.1. France Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Endocrine Testing Market

  • 19.1. Italy Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Endocrine Testing Market

  • 20.1. Spain Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Endocrine Testing Market

  • 21.1. Eastern Europe Endocrine Testing Market Overview
  • 21.2. Eastern Europe Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Endocrine Testing Market

  • 22.1. Russia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Endocrine Testing Market

  • 23.1. North America Endocrine Testing Market Overview
  • 23.2. North America Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Endocrine Testing Market

  • 24.1. USA Endocrine Testing Market Overview
  • 24.2. USA Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Endocrine Testing Market

  • 25.1. Canada Endocrine Testing Market Overview
  • 25.2. Canada Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Endocrine Testing Market

  • 26.1. South America Endocrine Testing Market Overview
  • 26.2. South America Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Endocrine Testing Market

  • 27.1. Brazil Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Endocrine Testing Market

  • 28.1. Middle East Endocrine Testing Market Overview
  • 28.2. Middle East Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Endocrine Testing Market

  • 29.1. Africa Endocrine Testing Market Overview
  • 29.2. Africa Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Endocrine Testing Market Competitive Landscape And Company Profiles

  • 30.1. Endocrine Testing Market Competitive Landscape
  • 30.2. Endocrine Testing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Roche Holding
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Siemens Healthineers
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Quest Diagnostics
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Endocrine Testing Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. PerkinElmer Inc.
  • 31.3. BioMerieux SA
  • 31.4. Beckman Coulter Inc.
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. SD Biosensor Inc.
  • 31.7. Qiagen N.V.
  • 31.8. Ortho Clinical Diagnostics
  • 31.9. Kronus Inc.
  • 31.10. Randox Laboratories Ltd.
  • 31.11. Fujirebio Diagnostics Inc.
  • 31.12. Inova Diagnostics Inc.
  • 31.13. Sekisui Diagnostics LLC
  • 31.14. Mercodia AB
  • 31.15. ZEUS Scientific Inc.

32. Global Endocrine Testing Market Competitive Benchmarking

33. Global Endocrine Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Endocrine Testing Market

35. Endocrine Testing Market Future Outlook and Potential Analysis

  • 35.1 Endocrine Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Endocrine Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Endocrine Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer